The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome

BACKGROUND: The Caprini Risk Score (CRS) is a validated predictive instrument for venous thrombosis. Previous investigators have shown that a high CRS is associated with a higher risk of mortality from thrombotic diseases. OBJECTIVE: The aim of this study was to assess the association between the CRS and prognosis of patients with acute coronary syndrome (ACS). METHODS: Secondary analysis of data from a retrospective cohort study was conducted. Patients were classified into 3 CRS-based categories (CRS ≤ 2, CRS = 3–4, and CRS ≥ 5, indicating low, medium, and high, respectively). Kaplan-Meier curves and Cox regression models were used to assess the prognosis of patients with ACS. All-cause mortality and cardiac mortality were the end points. RESULTS: Two hundred fifty-four patients (12.8%) died during follow-up. Multivariate Cox regression models identified CRS as an independent risk factor for all-cause mortality among patients with ACS (CRS = 3–4 vs CRS ≤ 2, hazard ratio: 3.268, 95% confidence interval: 1.396–7.647, P = .006; CRS ≥ 5 vs CRS ≤ 2, hazard ratio: 4.099, 95% confidence interval: 1.708–9.841, P = .002). Pearson correlation analysis showed a positive correlation between CRS and fibrinogen level (r = 0.486, R(2) = 0.765, P < .001) as well as D-dimer level (r = 0.480, R(2) = 0.465, P < .001). CONCLUSION: The CRS is a useful prognostic assessment instrument for patients with ACS, and the risk stratification of patients with ACS can be achieved based on their CRS at admission.